Skip to content
Subsido
Opening soonGrantEuropean Commission

Advancing bio-printing of living cells for regenerative medicine

- Biomedical scientists from academia and industry will gain access to entire bio-printing units designed to regenerate human tissue. - Healthcare professionals acquire information on the safe and effective use of equipment enabling advanced therapies with bio-printed human tissue. - Healthcare providers dispose of tools enabling them to treat conditions of unmet medical need. - Individual patients will benefit from a personalised approach to their respective medical condition thanks to the bio-printed regenerative medicine solution.

Key facts

Status
Opening soon
Kind of support
Grant
Call
Horizon Europe · Cluster 1 - Health (Single stage - 2027/2) · HORIZON-HLTH-2027-03
Company size
No restriction published
Where
European Union

Conditions

The conditions for qualifying. An eligibility check tests your details against each one.

  • At least 3 independent partners

Does your company qualify?

Give a few facts about your company and project, and see for each condition whether you meet it.

Eligibility check

Similar measures

OpenGrantEuropean Commission

EIC STEP Scale Up

The EIC STEP Scale Up call offers a total indicative budget of EUR 300 million for 2026, which is expected to rise to EUR 900 million for the period 2025-2027. Any unused amount from this b…

Rollingup to €30.0MEuropean Union
InnovationResearch and developmentInvestment
OpenGrantEuropean Commission

EIC Accelerator 2026 - Short proposal

The EIC Accelerator supports companies (principally SMEs, including start-ups) to scale up high impact innovations with the potential to create new markets or disrupt existing ones. The EIC…

RollingEuropean Union
InnovationResearch and developmentGrowth and scale-up

A check is an indication from the published conditions and the facts you give. Only the competent authority decides whether you are eligible.